
A first-in-class triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Studied for its potential in metabolic research and body composition.
For Research Use Only. This product is not intended for human consumption. By purchasing, you confirm this product will be used for research purposes only.
99%+ Purity
HPLC Verified
Fast Shipping
2-3 Day Delivery
Retatrutide is a groundbreaking triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. As the first compound to engage all three metabolic pathways, it represents a significant leap forward in metabolic research.
For research use only — not for human consumption.

A dual GIP/GLP-1 receptor agonist that has demonstrated significant effects in metabolic and weight management research. One of the most extensively studied incretin-based compounds.

A dual GLP-1/glucagon receptor agonist combining appetite regulation with enhanced energy expenditure. Actively studied for metabolic and hepatic fat research.

An essential coenzyme involved in over 500 enzymatic reactions, serving as a substrate for sirtuins and PARPs. Central to aging, DNA repair, and metabolic function research.

A mitochondrial-derived peptide that activates the AMPK signaling pathway. Studied as a potential exercise mimetic with effects on glucose metabolism and insulin sensitivity.